Loss of ARNTL Enhances ER Stress and Apoptosis in CKD Through Disruption of NRF2 Signaling
Authors:
- 9 June 2025
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 39 (11) , e70715
Abstract
Endoplasmic reticulum (ER) stress is a central driver of tubular cell apoptosis in chronic kidney disease (CKD), though the molecular pathways connecting ER stress to kidney injury remain unclear. In this study, we identify Aryl Hydrocarbon Receptor Nuclear Translocator‐Like (ARNTL) as a key regulator of the ER stress response and apoptosis in CKD, with significant implications for disease progression. ARNTL expression is markedly reduced in both CKD patients and CKD model mice, correlating with elevated markers of ER stress and reduced kidney function. In CKD patients, ARNTL expression in the kidney inversely correlates with serum creatinine and blood urea nitrogen levels, suggesting its protective role in maintaining renal health. Single‐cell sequencing further reveals that ARNTL is predominantly expressed in proximal tubular cells. In vitro studies demonstrate that the ER stress inducer tunicamycin (Tm) strongly suppresses ARNTL expression, whereas the ER stress inhibitor tauroursodeoxycholic acid (TUDCA) restores ARNTL levels and alleviates ER stress‐induced apoptosis, as indicated by reduced cleaved caspase‐3 and caspase‐9 levels. Notably, ARNTL silencing in HK2 cells intensifies ER stress, triggers mitochondrial apoptosis, promotes ROS production, and disrupts NRF2 activation. Moreover, ARNTL directly binds to the NRF2 promoter region and interacts with NRF2 through protein–protein binding. This study reveals the ARNTL‐NRF2 axis as a key protective pathway against stress‐induced injury in renal tubular cells, suggesting it as a promising therapeutic target for reducing tubular damage and inflammation in CKD.Keywords
Funding Information
- National Natural Science Foundation of China (82400858, 82370719, 82270761, 82200826, 82100744)
- National Key Research and Development Program of China (2023YFC2411803)
This publication has 49 references indexed in Scilit:
- Tauroursodeoxycholic acid ameliorates renal injury induced by COL4A3 mutationKidney International, 2024
- A clinical-stage Nrf2 activator suppresses osteoclast differentiation via the iron-ornithine axisCell Metabolism, 2024
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney DiseaseKidney International, 2024
- BMAL1 inhibits renal fibrosis and renal interstitial inflammation by targeting the ERK1/2/ELK-1/Egr-1 axisInternational Immunopharmacology, 2023
- Downregulation of ARNTL in renal tubules of diabetic db/db mice reduces kidney injury by inhibiting ferroptosisCellular Signalling, 2023
- The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2Cell Reports, 2023
- Proximal tubular Bmal1 protects against chronic kidney injury and renal fibrosis by maintaining of cellular metabolic homeostasisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
- Endoplasmic Reticulum Stress, NRF2 Signalling and Cardiovascular Diseases in a NutshellCurrent Atherosclerosis Reports, 2017
- Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathyFree Radical Biology and Medicine, 2016
- ER Stress Triggers Apoptosis by Activating BH3-Only Protein BimCell, 2007